Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Good
|
|
New words:
aberrant, Add, Agonism, agonist, aspect, billion, bring, cholesterol, circulating, Description, discomfort, fat, fatty, FFA, flushing, formation, GPCR, Hematologic, Herceptin, hyperactivation, interaction, intervention, intolerance, Ireland, LDL, MF, monotherapy, MPD, myeloma, niacin, pace, pathway, plasma, profound, RA, rebound, sending, sense, steady, sublet, transmembrane
Removed:
account, analog, attracting, Bausch, called, claimant, cliff, clone, commonly, declining, efficient, experiencing, expired, guidance, head, lab, lacking, Lomb, merging, neck, outsource, outsourcing, presence, restructure, retaining, Schutter, secreted, software, targeting, trading, white, worked, write
Filing tables
Filing exhibits
Related press release
INCY similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
Schedule of Convertible Subordinated Promissory Notes Issued in the Form of Exhibit 4.4.1
| Date Issued | Name of Note Holder | Principal Amount | Initial Conversion Price | Maturity Date | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| February 3, 2006 | Pfizer Ireland Pharmaceuticals(1) | $ | 10,000,000 | $ | 6.8423 | February 3, 2013 | ||||
October 10, 2007 | Pfizer Inc. | $ | 10,000,000 | $ | 9.75 | October 10, 2014 | ||||
- (1)
- Formerly known as Pfizer Overseas Pharmaceuticals